our investment mission

To invest in companies which contribute to the creation of a more efficient and effective healthcare system and a better quality of life.

our

investment

strategy

A Balanced Portfolio

R & D Sector (40%)

Approximately 40% of capital to be deployed in medical technologies, bioscience and research and development intensive companies (“R&D Sector”) including the following sub-sectors:

Z

Drug development

Z

Innovative medical devices and equipment

Z

Healthcare supplements and natural remedies

  • R & D SECTOR 40%

Medical service sector (60%)

Approximately 60% of capital to be deployed in production, operational and medical services companies  (“Medical Services Sector”) including the following sub-sectors:

Z

Pharmaceutical production and distribution

Z

Hospital & clinics and pharmacy chains

Z

Services that support the healthcare system

  • MEDICAL SERVICE SECTOR 60%

Our portfolio

SINGAPORE FUND

HEALTHCARE SECTOR
ATTRACTIVE GROWTH OPPORTUNITIES

healthcare fund

Global healthcare spending expected to accelerate at average rate of 5% growth p.a to $9.3 trillion* in 2018, approx 24% ($2.2 trillion) from Asia

* World industry outlook: Healthcare and pharmaceuticals, The Economist Intelligence Unit, May 2014

RISE OF ASIA

Asia is now the most exciting part of the world for healthcare businesses with rapidly ageing demographics and rising incomes across the region.

AFFLUENT LIFESTYLE 

Affluence in Asia has led to surge in chronic ailments like diabetes, coronary diseases and others, resulting in a growing need in preventive and well-being healthcare.

HEALTHCARE REFORM

Driven by the need to control cost and to provide better coverage, the healthcare system is undergoing radical reforms which provide abundant opportunities for innovation.

WIDE SPECTRUM

Healthcare investments range from defensive and mature cash generating assets (e.g. clinic chains & pharmacies) to small cap biotech or drug discovery companies that potentially offer multi-bagger returns.

CROSS BORDER INTEREST

Asian healthcare companies are increasingly seeking to expand across the region to build scale and scope of operations.

55 Market Street, #10-01 Singapore  048941

info@wintopcapital.com.sg

+65 6521 2843